GRFS
Grifols, S.A.
NasdaqGSUSDEQUITY
Healthcare
DELAYED
Neutral
-17/100
Last price
7.52
▲ 0.11 (1.48%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
7.52
Prev close
7.41
Day high
7.57
Day low
7.42
Volume
326.10K
Market cap
$5.12B
P/E (TTM)
9.64
52W range
6.96 – 9.90
Day trading desk
Gap from prior close
+1.48%
Prior close 7.41
VWAP
—
—
Relative volume
0.00×
Quiet session
Session range
—
7.52 – 7.52
Position in range
—
—
ATR (14D)
0.14
1.86% of price
Prior day high
7.54
PDH
Prior day low
7.29
PDL
Bid / ask spread
—
Quote not published
Session volume
—
Avg 583.27K
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
+3.01%
+1.1%
1M
-3.59%
-4.7%
3M
+2.87%
-1.6%
6M
-7.16%
-25.3%
YTD
-19.57%
-33.8%
1Y
-24.42%
-40.8%
3Y
-17.72%
-100.0%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on GRFS open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
0
Total on file
Fundamentals
Market cap$5.12B
Enterprise value$21.49B
Revenue (TTM)$7.42B
Gross profit$2.80B
EBITDA$1.65B
Net income$452.00M
EPS (TTM)$0.78
Free cash flow$572.92M
Total cash$537.00M
Total debt$9.36B
Book value / share$4.59
Shares outstanding258.22M
Float836.45M
Short % of float—
Dividend yield1.40%
Beta (5Y)1.20
Valuation & profitability ratios
Trailing P/E9.64
Forward P/E5.21
PEG ratio0.19
Price / sales—
Price / book1.64
EV / revenue2.90
EV / EBITDA13.06
Gross margin37.79%
Operating margin15.90%
Profit margin6.09%
Return on equity6.93%
Return on assets4.23%
Debt / equity117.24
Current ratio2.37
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $7.52B | $7.21B | $6.59B | $6.06B | +4.3% |
| Operating revenue | $7.28B | $7.00B | $6.39B | $5.81B | +4.0% |
| Cost of revenue | $4.67B | $4.42B | $4.11B | $3.85B | +5.6% |
| Gross profit | $2.86B | $2.79B | $2.48B | $2.21B | +2.3% |
| Research & development | $426.00M | $384.00M | $395.00M | $361.14M | +10.9% |
| Selling, general & admin | $1.06B | $1.14B | $1.27B | $1.11B | -7.0% |
| Total operating expense | $1.61B | $1.64B | $1.76B | $1.53B | -1.9% |
| Operating income | $1.25B | $1.16B | $718.00M | $678.96M | +8.3% |
| Net interest income | -$605.00M | -$701.00M | -$560.00M | -$462.67M | +13.7% |
| Pre-tax income | $615.00M | $444.00M | $206.00M | $338.01M | +38.5% |
| Tax provision | $115.00M | $231.00M | $43.00M | $90.11M | -50.2% |
| Net income | $402.00M | $157.00M | $42.00M | $185.03M | +156.1% |
| Net income to common | $402.00M | $157.00M | $42.00M | $185.03M | +156.1% |
| Basic EPS | 0.59 | 0.23 | 0.09 | 0.31 | +156.5% |
| Diluted EPS | 0.59 | 0.23 | 0.09 | 0.31 | +156.5% |
| EBIT | $1.19B | $1.05B | $722.00M | $782.56M | +13.9% |
| EBITDA | $1.64B | $1.48B | $1.17B | $1.19B | +10.6% |
| Basic shares | 680.51M | 679.67M | 679.76M | 679.81M | +0.1% |
| Diluted shares | 681.57M | 679.92M | 679.76M | 679.81M | +0.2% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $801.00M | $980.00M | $529.58M | $549.21M | -18.3% |
| Cash & short-term investments | $824.00M | $1.00B | $544.50M | $580.24M | -17.7% |
| Accounts receivable | $651.00M | $705.00M | $645.11M | $609.08M | -7.7% |
| Inventory | $3.30B | $3.56B | $3.48B | $3.24B | -7.4% |
| Total current assets | $5.07B | $5.73B | $6.13B | $4.69B | -11.4% |
| Property, plant & equipment | $4.05B | $4.31B | $4.19B | $4.28B | -6.0% |
| Goodwill & intangibles | $9.56B | $10.33B | $9.63B | $9.96B | -7.4% |
| Total assets | $19.71B | $21.41B | $20.99B | $21.23B | -7.9% |
| Total current liabilities | $2.02B | $2.16B | $2.33B | $2.02B | -6.4% |
| Current debt | $410.00M | $551.00M | $880.81M | $578.92M | -25.6% |
| Long-term debt | $8.07B | $8.42B | $8.98B | $8.15B | -4.1% |
| Total debt | $9.57B | $10.11B | $10.97B | $9.75B | -5.4% |
| Total liabilities | $12.11B | $12.80B | $13.48B | $13.25B | -5.4% |
| Retained earnings | $300.00M | $157.00M | $42.32M | $0 | +91.1% |
| Shareholder equity | $5.27B | $5.88B | $5.37B | $5.65B | -10.4% |
| Working capital | $3.06B | $3.57B | $3.81B | $2.67B | -14.5% |
| Net tangible assets | -$4.29B | -$4.45B | -$4.27B | -$4.31B | +3.5% |
| Shares issued | 687.55M | 687.55M | 687.55M | 687.55M | 0.0% |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Net income | $615.00M | $444.00M | $206.00M | $338.01M | — | +38.5% |
| Depreciation & amortisation | $450.00M | $438.00M | $446.00M | $410.98M | — | +2.7% |
| Change in working capital | -$31.00M | $23.00M | -$363.00M | -$584.35M | — | -234.8% |
| Operating cash flow | $1.05B | $902.00M | $217.00M | -$1.43M | — | +16.1% |
| Capital expenditure | -$423.00M | -$372.00M | -$310.00M | -$392.87M | — | -13.7% |
| Investing cash flow | -$579.00M | $886.00M | -$394.00M | -$2.00B | — | -165.3% |
| Share buybacks | — | $0 | $0 | -$3.46M | -$125.70M | — |
| Dividends paid | -$128.00M | -$1.00M | $0 | -$592.00K | — | -12,700.0% |
| Financing cash flow | -$529.00M | -$1.36B | $172.00M | -$164.90M | — | +61.1% |
| Free cash flow | $624.00M | $530.00M | -$93.00M | -$394.30M | — | +17.7% |
| End cash position | $825.00M | $980.00M | $529.00M | $549.21M | — | -15.8% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $1.87B | $1.70B | $1.98B | $1.89B | $1.79B | +10.2% |
| Operating revenue | $1.87B | $1.70B | $1.74B | $1.89B | $1.79B | +10.2% |
| Cost of revenue | $1.17B | $1.08B | $1.29B | $1.15B | $1.09B | +8.3% |
| Gross profit | $705.00M | $620.00M | $686.84M | $744.00M | $695.00M | +13.7% |
| Research & development | $87.00M | $90.00M | $136.74M | $96.00M | $96.00M | -3.3% |
| Selling, general & admin | $289.00M | $281.00M | $155.30M | $298.00M | $325.00M | +2.8% |
| Total operating expense | $376.00M | $371.00M | $411.46M | $394.00M | $421.00M | +1.3% |
| Operating income | $329.00M | $249.00M | $275.38M | $350.00M | $274.00M | +32.1% |
| Net interest income | -$79.00M | -$139.00M | -$136.99M | -$158.00M | -$154.00M | +43.2% |
| Pre-tax income | $247.00M | $112.00M | $111.10M | $191.00M | $115.00M | +120.5% |
| Tax provision | $64.00M | $24.00M | -$14.68M | $52.00M | $23.00M | +166.7% |
| Net income | $155.00M | $73.00M | $98.25M | $117.00M | $60.00M | +112.3% |
| Net income to common | $155.00M | $73.00M | $98.25M | $117.00M | $60.00M | +112.3% |
| Basic EPS | 0.23 | 0.11 | — | 0.17 | 0.09 | +112.3% |
| Diluted EPS | 0.23 | 0.11 | — | 0.17 | 0.09 | +112.3% |
| EBIT | $329.00M | $249.00M | $219.09M | $350.00M | $274.00M | +32.1% |
| EBITDA | $436.00M | $353.00M | $347.45M | $457.00M | $386.00M | +23.5% |
| Basic shares | 680.58M | 680.58M | — | 679.73M | 680.41M | +0.0% |
| Diluted shares | 680.58M | 680.58M | — | 679.73M | 680.41M | +0.0% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-06-30 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $513.00M | $702.00M | $801.00M | $558.69M | -26.9% |
| Cash & short-term investments | $529.00M | $758.00M | $824.00M | $565.80M | -30.2% |
| Accounts receivable | $686.00M | $863.00M | $651.00M | $748.96M | -20.5% |
| Inventory | $3.49B | $3.46B | $3.30B | $3.35B | +1.0% |
| Total current assets | $5.30B | $5.25B | $5.07B | $5.25B | +1.0% |
| Property, plant & equipment | $4.06B | $3.16B | $4.05B | $4.04B | +28.2% |
| Goodwill & intangibles | $9.82B | $10.62B | $9.56B | $9.60B | -7.6% |
| Total assets | $20.09B | $20.08B | $19.71B | $19.77B | +0.1% |
| Total current liabilities | $2.24B | $2.12B | $2.02B | $1.99B | +5.3% |
| Current debt | $303.00M | — | $410.00M | $282.14M | — |
| Long-term debt | $7.17B | — | $8.07B | $7.45B | — |
| Total debt | $8.52B | $9.67B | $9.57B | $8.82B | -11.9% |
| Total liabilities | $12.11B | $12.23B | $12.11B | $12.17B | -1.0% |
| Retained earnings | $227.00M | $73.00M | $300.00M | $176.79M | +211.0% |
| Shareholder equity | $5.55B | $5.46B | $5.27B | $5.17B | +1.6% |
| Working capital | $3.07B | $3.13B | $3.06B | $3.26B | -1.9% |
| Net tangible assets | -$4.28B | -$5.17B | -$4.29B | -$4.43B | +17.2% |
| Shares issued | 687.56M | 680.58M | 687.55M | 687.55M | +1.0% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Net income | $286.00M | $73.00M | $311.25M | $246.00M | $60.00M | +291.8% |
| Depreciation & amortisation | $107.00M | $104.00M | $128.37M | $107.00M | $112.00M | +2.9% |
| Change in working capital | -$100.00M | -$107.00M | $164.75M | -$131.00M | -$128.00M | +6.5% |
| Operating cash flow | $227.00M | $110.00M | $430.86M | $157.00M | $136.00M | +106.4% |
| Capital expenditure | -$119.00M | -$90.00M | -$134.15M | -$94.00M | -$88.00M | -32.2% |
| Investing cash flow | -$128.00M | -$118.00M | -$151.32M | -$131.00M | -$174.00M | -8.5% |
| Dividends paid | — | — | -$25.62M | — | — | — |
| Financing cash flow | -$295.00M | -$130.00M | -$75.18M | -$157.00M | -$158.00M | -126.9% |
| Free cash flow | $108.00M | $20.00M | $296.71M | $63.00M | $48.00M | +440.0% |
| End cash position | $513.00M | $702.00M | $825.00M | $561.00M | $753.00M | -26.9% |
Options analytics
Put / call volume
1.50
Put-heavy session
Put / call open interest
—
Positioning, not flow
Max pain
7.00
-6.9% from spot
ATM implied vol
12.5%
Nearest strike to spot
Skew (10% OTM)
0.0%
Calls bid over puts
Call volume
2
Contracts, this expiry
Put volume
3
Contracts, this expiry
Heaviest call OI
7.00
0 contracts
Heaviest put OI
7.00
0 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 0.28 | — | — |
| Mar 2026 | 0.15 | — | — |
| Dec 2025 | 0.29 | — | — |
| Sep 2025 | 0.28 | — | — |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 0.30 | 1 | $1.97B | +5.6% |
| Next quarter | 0.39 | 1 | $2.08B | +4.8% |
| Current year | 1.16 | 2 | $7.65B | +1.7% |
| Next year | 1.44 | 2 | $8.13B | +6.3% |
Analyst targets & ownership
Mean target$10.87
High target$11.73
Low target$10.00
Implied upside44.48%
Analyst count2
ConsensusNONE
Strong buy / Buy0 / 1
Hold1
Sell / Strong sell0 / 0
Held by insiders0.00%
Held by institutions57.29%
Institutions holding211
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
7.33
+2.58% from price
SMA 20
7.40
+1.57% from price
SMA 50
7.71
-2.48% from price
SMA 100
7.62
-1.26% from price
SMA 200
8.14
-7.60% from price
EMA 12
7.39
+1.76% from price
EMA 26
7.48
+0.59% from price
EMA 50
7.57
-0.67% from price
RSI (14)
51.8
Neutral
MACD (12,26,9)
-0.09
Hist 0.03
ATR (14)
0.14
1.86% of price
Realised vol 30D
20.4%
Annualised
Bollinger upper
7.69
20, 2σ
Bollinger lower
7.12
20, 2σ
50 / 200 cross
Death
7.71 vs 8.14
Trend bias
Below 200
-7.60%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.90
Less volatile than market
Correlation to SPY
0.37
Loosely linked
Realised vol 30D
20.4%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-28.0%
Peak to trough
Max drawdown 5Y
-63.4%
Peak to trough
ATR 14
0.14
1.86% of price
Beta (reported)
1.20
5Y monthly, from filing
Short interest
Shares short
3.41M
Prior 3.52M
Change vs prior
-2.9%
Shorts covering
% of float
—
—
% of shares out
0.50%
Against total outstanding
Days to cover
8.5
Crowded exit
Float
836.45M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 8, 25 | JP Morgan | MAINTAINED | Neutral | Neutral |
| Jun 17, 25 | JP Morgan | MAINTAINED | Neutral | Neutral |
| Mar 12, 24 | Deutsche Bank | DOWNGRADE | Hold | Sell |
| Dec 5, 23 | JP Morgan | MAINTAINED | Neutral | Neutral |
| Nov 5, 21 | Deutsche Bank | DOWNGRADE | Buy | Hold |
| Mar 23, 21 | Credit Suisse | UPGRADE | Neutral | Outperform |
| Mar 11, 21 | HSBC | UPGRADE | Hold | Buy |
| Oct 28, 19 | Santander | UPGRADE | Hold | Buy |
| Jun 27, 19 | JP Morgan | UPGRADE | Neutral | Overweight |
| Feb 8, 19 | Berenberg | DOWNGRADE | Buy | Hold |
| Jan 2, 19 | Morgan Stanley | MAINTAINED | Underweight | Underweight |
| Oct 1, 18 | Morgan Stanley | MAINTAINED | Underweight | Underweight |
Dividends & splits
Forward rate$0.11 / yr
Forward yield1.40%
5-year avg yield2.14%
Payout ratio37.97%
Ex-dividend dateJul 2, 2026
Next pay dateJul 9, 2026
Last split2:1
Split dateJan 4, 2016
SEC filings
Corporate Changes & Voting Matters
6-K · 2026-07-30
Corporate Changes & Voting Matters
6-K · 2026-07-29
Corporate Changes & Voting Matters
6-K · 2026-06-22
Corporate Changes & Voting Matters
6-K · 2026-06-18
Corporate Changes & Voting Matters
6-K · 2026-05-15
Corporate Changes & Voting Matters
6-K · 2026-05-07
Periodic Financial Reports
20-F · 2026-04-17
Corporate Changes & Voting Matters
6-K · 2026-04-14
Headlines
Grifols (BME:GRF) Stock May Be Below Fair Value On Earnings
Simply Wall St. · 11d ago
European Equities Traded in the US as American Depositary Receipts Edge Higher in Friday Trading; Down for Week
MT Newswires · 12d ago
GRFS vs. SDZNY: Which Stock Should Value Investors Buy Now?
Zacks · 13d ago
European Equities Traded in the US as American Depositary Receipts Drop in Thursday Trading
MT Newswires · 27d ago
GRFS or SDZNY: Which Is the Better Value Stock Right Now?
Zacks · 29d ago
European Equities Traded in the US as American Depositary Receipts Edge Higher in Tuesday Trading
MT Newswires · 36d ago
European Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading
MT Newswires · 49d ago
OPSEU/SEFPO: Permanently end for-profit plasma collection to protect public health
GlobeNewswire · 54d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.